We used a urethral stent for management of high-age and high-risk patients with benign prostatic hyperplasia (BPH) who needed surgical therapy. Nine patients were treated by this method. Chief complaints were urinary retention in 6 patients, dysuria with much residual urine in 2 and dysuria in 1. Blood loss and complications of the method were minimal. Postoperatively, 8 of the patients were able to void and on the average, residual urine of the patients was approximately 10 ml. Implantation of the urethral stent is a safe and non-invasive therapy for the patients who are unsuitable for invasive therapy.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
benign prostatic
8
urethral stent
8
therapy patients
8
residual urine
8
patients
6
[urethral stent
4
stent memotherm
4
memotherm treatment
4
treatment benign
4
prostatic hyperplasia]
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!